Posted On: 02/19/2016 9:09:44 PM
Post# of 30066
On any message board that will be at least a dozen or two short posters and even more flippers. Some of them will panic. Some will post and down play messages. Some will bash. Many will strategize on their private Skype channels, message board or phone each other all weekend.
None will be able to explain the late Friday PR with two conferences on Monday and Tuesday and will post all weekend on why the cap is $5M and each asset and ODD is worth $500K.
Even the hard core bashers have said time and again the market cap make no sense. Now with funding to move forward, do you really think ESS and everything else is valued at $5M? Try $200M, $400M, ?
I've posted previously what the market cap was on RGIN before litigation, ODD, grant, etc. and the value in the lawsuit was into the billions. A mc of $200M would be a 40 bagger or $400m @ 80 from here.
There are always going to be people that sell at .32. Good for them. If you do, good for you. We've all jumped ship premature on other stocks. You got to ask yourself, why is more than one investor is willing to invest millions.
Dustin $1M. International Infusion $1.5M. Lastest round $3M.
Pattern? I think so.
SEETHRUEQUITY & THE BREWER GROUP 2ND ANNUAL INNOVATIONS INVESTOR CONFERENCE - February 22, 2016
http://steconference.com/presenting-companies/
1st Annual Neuroscience BioPartnering & Investment Forum - Feb. 23, 2016
http://www.sachsforum.com/1st-annual-neurosci...ences.html
Agenda:
Advances in Parkinson’s Disease and Lewy Body Dementia
13.35 - Chaired: Ginger Johnson, Vice President, Defined Health
Panellists:
Andrew Singleton, Chief, Molecular Genetics Section and Laboratory of Neurogenetics, NIA, NIH
Gerald Commissiong , President & CEO, Amarantus BioScience Holdings, Inc.
Kees Been, CEO, Lysosomal Therapeutics
Timo Veromaa, President and CEO, Biotie Therapies Corp.
Todd Sherer, CEO, Michael J. Fox Foundation
Presenting Track D
16.40- Moderated by:
Amarantus BioScience Holdings, Inc.
None will be able to explain the late Friday PR with two conferences on Monday and Tuesday and will post all weekend on why the cap is $5M and each asset and ODD is worth $500K.
Even the hard core bashers have said time and again the market cap make no sense. Now with funding to move forward, do you really think ESS and everything else is valued at $5M? Try $200M, $400M, ?
I've posted previously what the market cap was on RGIN before litigation, ODD, grant, etc. and the value in the lawsuit was into the billions. A mc of $200M would be a 40 bagger or $400m @ 80 from here.
There are always going to be people that sell at .32. Good for them. If you do, good for you. We've all jumped ship premature on other stocks. You got to ask yourself, why is more than one investor is willing to invest millions.
Dustin $1M. International Infusion $1.5M. Lastest round $3M.
Pattern? I think so.
SEETHRUEQUITY & THE BREWER GROUP 2ND ANNUAL INNOVATIONS INVESTOR CONFERENCE - February 22, 2016
http://steconference.com/presenting-companies/
1st Annual Neuroscience BioPartnering & Investment Forum - Feb. 23, 2016
http://www.sachsforum.com/1st-annual-neurosci...ences.html
Agenda:
Advances in Parkinson’s Disease and Lewy Body Dementia
13.35 - Chaired: Ginger Johnson, Vice President, Defined Health
Panellists:
Andrew Singleton, Chief, Molecular Genetics Section and Laboratory of Neurogenetics, NIA, NIH
Gerald Commissiong , President & CEO, Amarantus BioScience Holdings, Inc.
Kees Been, CEO, Lysosomal Therapeutics
Timo Veromaa, President and CEO, Biotie Therapies Corp.
Todd Sherer, CEO, Michael J. Fox Foundation
Presenting Track D
16.40- Moderated by:
Amarantus BioScience Holdings, Inc.
(18)
(1)
